1 - 25 of 42 results for author:"Emmerich J." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| Lack of association of non-synonymous FUT2 and ALPL polymorphisms with venous thrombosis. Tregouet D.A., Sabater-Lleal M., Bruzelius M., Emmerich J., Amouyel P., Dartigues J.F., Kieler H., Morange P.E. J. Thromb. Haemost. 10:1693-1695(2012) · Mapped (10) |
| IL-10 elicits IFNgamma-dependent tumor immune surveillance. Mumm J.B., Emmerich J., Zhang X., Chan I., Wu L., Mauze S., Blaisdell S., Basham B., Dai J., Grein J. et al. Cancer Cell 20:781-796(2011) · Mapped (19) |
| KNG1 Ile581Thr and susceptibility to venous thrombosis. Morange P.E., Oudot-Mellakh T., Cohen W., Germain M., Saut N., Antoni G., Alessi M.C., Bertrand M., Dupuy A.M., Letenneur L. et al. Blood 117:3692-3694(2011) · Mapped (6) |
| Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Smadja D.M., d'Audigier C., Bieche I., Evrard S., Mauge L., Dias J.V., Labreuche J., Laurendeau I., Marsac B., Dizier B. et al. Arterioscler. Thromb. Vasc. Biol. 31:551-559(2011) · Mapped (6) |
| Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels. Morange P.E., Saut N., Antoni G., Emmerich J., Tregouet D.A. J. Thromb. Haemost. 9:229-231(2011) · Mapped (31) |
| A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism. Antoni G., Morange P.E., Luo Y., Saut N., Burgos G., Heath S., Germain M., Biron-Andreani C., Schved J.F., Pernod G. et al. J. Thromb. Haemost. 8:2671-2679(2010) · Mapped (5) |
| Protein S inherited qualitative deficiency: novel mutations and phenotypic influence. Alhenc-Gelas M., Canonico M., Morange P.E., Emmerich J. J. Thromb. Haemost. 8:2718-2726(2010) · Mapped (28) |
| The minor allele of GP6 T13254C is associated with decreased platelet activation and a reduced risk of recurrent cardiovascular events and mortality: results from the SMILE-Platelets project. Snoep J.D., Gaussem P., Eikenboom J.C., Emmerich J., Zwaginga J.J., Holmes C.E., Vos H.L., de Groot P.G., Herrington D.M., Bray P.F. et al. J. Thromb. Haemost. 8:2377-2384(2010) · Mapped (2) |
| Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio. Moreno J.A., Dejouvencel T., Labreuche J., Smadja D.M., Dussiot M., Martin-Ventura J.L., Egido J., Gaussem P., Emmerich J., Michel J.B. et al. Arterioscler. Thromb. Vasc. Biol. 30:1253-1262(2010) · Mapped (6) |
| A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. Morange P.E., Bezemer I., Saut N., Bare L., Burgos G., Brocheton J., Durand H., Biron-Andreani C., Schved J.F., Pernod G. et al. Am. J. Hum. Genet. 86:592-595(2010) · Mapped (3) |
| C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. Buil A., Tregouet D.A., Souto J.C., Saut N., Germain M., Rotival M., Tiret L., Cambien F., Lathrop M., Zeller T. et al. Blood 115:4644-4650(2010) · Mapped (8) |
| Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholipid syndrome. Smadja D., Gaussem P., Roncal C., Fischer A.M., Emmerich J., Darnige L. Lupus 19:837-843(2010) · Mapped (12) |
| Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency. Picard V., Chen J.M., Tardy B., Aillaud M.F., Boiteux-Vergnes C., Dreyfus M., Emmerich J., Lavenu-Bombled C., Nowak-Gottl U., Trillot N. et al. Hum. Genet. 127:45-53(2010) · Mapped (10) |
| Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Tregouet D.A., Heath S., Saut N., Biron-Andreani C., Schved J.F., Pernod G., Galan P., Drouet L., Zelenika D., Juhan-Vague I. et al. Blood 113:5298-5303(2009) · Mapped (144) |
| Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Smadja D.M., Bieche I., Silvestre J.S., Germain S., Cornet A., Laurendeau I., Duong-Van-Huyen J.P., Emmerich J., Vidaud M., Aiach M. et al. Arterioscler. Thromb. Vasc. Biol. 28:2137-2143(2008) · Mapped (5) |
| Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nedjic J., Aichinger M., Emmerich J., Mizushima N., Klein L. Nature 455:396-400(2008) · Mapped (5) |
| Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. Smadja D.M., Bieche I., Susen S., Mauge L., Laurendeau I., d'Audigier C., Grelac F., Emmerich J., Aiach M., Gaussem P. J. Cell. Mol. Med. 13:2534-2546(2009) · Mapped (8) |
| No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease. Smadja D.M., Loriot M.A., Hindorff L.A., Mellottee L., Gaussem P., Emmerich J. Thromb. Haemost. 99:970-972(2008) · Mapped (2) |
| A two adenine insertion polymorphism in the 3' untranslated region of factor VII gene is associated with peripheral arterial disease but not with venous thrombosis. Results of case-control studies. Serve E., Reny J.L., Akhavan S., Emmerich J., Fischer A.M., Tapon-Bretaudiere J. Thromb. Haemost. 98:733-737(2007) · Mapped (5) |
| Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism. Zee R.Y., Michaud S.E., Diehl K.A., Chasman D.I., Emmerich J., Gaussem P., Aiach M., Ridker P.M. Atherosclerosis 197:694-699(2008) · Mapped (4) |
| Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Aschenbrenner K., D'Cruz L.M., Vollmann E.H., Hinterberger M., Emmerich J., Swee L.K., Rolink A., Klein L. Nat. Immunol. 8:351-358(2007) · Mapped (7) |
| Alpha1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia. Perdu J., Gimenez-Roqueplo A.P., Boutouyrie P., Beaujour S., Laloux B., Nau V., Fiquet-Kempf B., Emmerich J., Tichet J., Plouin P.F. et al. J. Hypertens. 24:705-710(2006) · Mapped (7) |
| Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Straczek C., Oger E., Yon de Jonage-Canonico M.B., Plu-Bureau G., Conard J., Meyer G., Alhenc-Gelas M., Levesque H., Trillot N., Barrellier M.T. et al. Circulation 112:3495-3500(2005) · Mapped (21) |
| Cyclin D does not provide essential Cdk4-independent functions in Drosophila. Emmerich J., Meyer C.A., de la Cruz A.F., Edgar B.A., Lehner C.F. Genetics 168:867-875(2004) · Mapped (33) |
| The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. Reny J.L., Alhenc-Gelas M., Fontana P., Bissery A., Julia P.L., Fiessinger J.N., Aiach M., Emmerich J. J. Thromb. Haemost. 2:1334-1340(2004) · Mapped (21) |